CXCR4 inhibitor GPC-100
Term · Oncology and biomedicine · MLC-T-ONC-012850
An inhibitor of C-X-C chemokine receptor type 4 (CXCR4), with potential hematopoietic stem cell (HSC)-mobilizing activity. Upon administration, CXCR4 inhibitor GPC-100 targets and binds to CXCR4, thereby preventing the binding of stromal-cell derived factor-1 (SDF-1; C-X-C motif chemokine ligand 12; CXCL12) to CXCR4. This results in HSC release from the bone marrow and HSC movement into the peripheral circulation. The CXCL12/CXCR4 signaling pathway plays an important role in the migration and retention of HSC in the bone marrow.
| Identifier | MLC-T-ONC-012850 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012850",
"term": "CXCR4 inhibitor GPC-100",
"field": "Oncology and biomedicine",
"definition": "An inhibitor of C-X-C chemokine receptor type 4 (CXCR4), with potential hematopoietic stem cell (HSC)-mobilizing activity. Upon administration, CXCR4 inhibitor GPC-100 targets and binds to CXCR4, thereby preventing the binding of stromal-cell derived factor-1 (SDF-1; C-X-C motif chemokine ligand 12; CXCL12) to CXCR4. This results in HSC release from the bone marrow and HSC movement into the peripheral circulation. The CXCL12/CXCR4 signaling pathway plays an important role in the migration and retention of HSC in the bone marrow.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cxcr4-inhibitor-gpc-100/"
}
Record 5,548 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.